Here's a suggestion you don't hear every day: if you're diagnosed with low-risk prostate cancer, get your testosterone checked. It sounds backwards, since high testosterone was long blamed for fueling the disease. Yet a new MD Anderson study of nearly 1,000 men on Active Surveillance links low testosterone with a jump to more aggressive, higher grade cancer. keep reading

Why do men die younger than women? Part of it is biology. But culture plays a big role too. Many men are raised to hide pain, take risks and skip the doctor. A new opinion piece calls for prevention-based care for men, and new data showing early heart risk in men backs her up. If it's been a year since your last checkup, now is the time. keep reading

Can what's on your plate keep prostate cancer in check? The evidence keeps growing. A new analysis of more than 6,000 prostate cancer patients found that men who followed the Mediterranean diet or the Alternative Healthy Eating Index lived longer after diagnosis. It builds on a Johns Hopkins study linking healthy diets with slower progression. keep reading

Your father had prostate cancer. Maybe your brother too. Does that mean you are next? Not necessarily. A man with a brother who was diagnosed has about three times the chance of developing it, yet only around 10% of prostate cancers are truly inherited. Knowing your family history, and acting on it, is one of the best ways to stay ahead. keep reading

A rising PSA after radiation can feel like starting over. But if the recurrence is still contained in the prostate, the whole gland may not need treatment again. Salvage focal ablation goes after the tumor alone. In a 2026 study of 51 men, 84% were free of clinically significant cancer at two years, with continence preserved in 94%. keep reading

Not all prostate MRI scans are equal. A poorly captured image can make a significant tumor look less threatening than it is, or hide it entirely. Researchers now use the PI-QUAL score to grade scan quality, and when the score comes back low, the authors of a new study recommend repeating the MRI and adding systematic biopsy samples. keep reading

The PSA test is a two-sided coin. On one side, it has caught countless prostate cancers while a cure was still possible. On the other, it has triggered needle biopsies and whole-gland treatment for tumors that would never have caused harm. Experts now point to MRI as the step that keeps the early warning while cutting the harm. keep reading

About 30 million American men live with erectile dysfunction, and many suffer in silence out of shame. Yet ED is one of the most treatable conditions in men's health. The first step is finding the cause, physical or psychological, because treating the root problem often matters as much as the pill that restores the erection. keep reading

The brain makes upward of 35,000 decisions a day, and few weigh as heavily as choosing a prostate cancer treatment. When a biopsy hints at a riskier cancer, genomic testing of the tissue can settle the question. A reassuring result gives men real confidence in Active Surveillance or focal therapy, and new 2026 research shows what a high score can warn about. keep reading

Why doesn't every man with a high PSA get an MRI before a needle biopsy? Cost is one barrier. The other is capacity: too few 3T scanners, too few expert readers, and too much time per scan. New AI tools are shortening scan times by roughly 39% and cutting interpretation work, bringing wider MRI access within reach for more men. keep reading